OLMIZEST BETA-50

About

OLMIZEST BETA-50 is a combination antihypertensive medication, typically containing Olmesartan, an Angiotensin Receptor Blocker (ARB), and a beta-blocker like Metoprolol. Olmesartan works by blocking the action of angiotensin II, a potent vasoconstrictor, leading to vasodilation and reduced blood pressure. Metoprolol, a beta-1 selective adrenergic blocker, reduces heart rate and cardiac output, further contributing to blood pressure reduction. This dual mechanism provides comprehensive control of hypertension, particularly in patients whose blood pressure is not adequately controlled by monotherapy. It helps to reduce the risk of cardiovascular complications such as stroke, heart attack, and kidney damage associated with high blood pressure. The synergistic action of these two classes of drugs offers a robust approach to managing moderate to severe hypertension, improving patient outcomes and quality of life.

Uses

• Treatment of essential hypertension.
• Blood pressure control in patients unresponsive to monotherapy.
• Reduction of cardiovascular risk in hypertensive patients.
• Management of hypertension with co-existing conditions like angina.

Directions For Use

Take once daily, preferably at the same time each day, with or without food, as directed by your physician.

Benefits

• Provides effective blood pressure reduction.
• Offers a dual mechanism of action for robust control.
• Reduces the risk of stroke and heart attack.
• Improves overall cardiovascular outcomes.
• May be beneficial for patients with angina.
• Generally well-tolerated once dosage is optimized.

Side Effects

• Dizziness
• Fatigue
• Bradycardia (slow heart rate)
• Hypotension (low blood pressure)
• Nausea
• Diarrhea
• Headache
• Cold extremities
• Bronchospasm (rare, with non-selective beta-blockers)
• Erectile dysfunction
• Hyperkalemia (due to ARB)
• Renal dysfunction (rare, especially in susceptible patients)

Safety Measures

• Alcohol - Avoid excessive alcohol as it can exacerbate dizziness and lower blood pressure, increasing the risk of orthostatic hypotension.
• Pregnancy - Contraindicated, especially in the second and third trimesters, due to significant risk of fetal renal damage and death from the ARB component.
• Breastfeeding - Not recommended as both components can pass into breast milk and potentially affect the infant.
• Liver - Use with caution in patients with liver impairment; dose adjustments may be necessary.
• Kidney - Use with caution in renal impairment; monitor kidney function closely, especially with the ARB component, as it can worsen renal function in susceptible patients.
• Lung - Use with caution in patients with asthma or COPD, as beta-blockers can worsen respiratory symptoms, even with beta-1 selective agents at higher doses.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.